Syrhatech has emerged as a key player in Europe’s medical device landscape, with a strong commitment to quality and readiness for industrial scale-up.
Company Description
Syrhatech is a Contract Development and Manufacturing Organization (CDMO) specializing in injectable medical devices based on hyaluronic acid (HA) and other biopolymers. The company offers end-to-end development services, from formulation and analytical testing to sterile manufacturing.